Role of low-molecular-weight heparin in the early intervention of severe preeclampsia.

doi:10.7504/fk2014090105

Abstract

Abstract:

Abstract: Severe preeclampsia is a serious harm disease during pregnancy, often accompanied by serious maternal and fetal complications, leading to adverse pregnancy outcomes. Low-molecular-weight heparin, known for anticoagulation, anti-inflammation and protecting vascular endothelial, can play its role in the pathological and physiological process of severe preeclampsia in many ways,and it also can be used as an early intervention treatment for severe preeclampsia, so it has important significance in reducing maternal complications and slowing the progression of the disease.

Key words: severe preeclampsia, low-molecular- weight heparin, intervention

摘要：

重度子痫前期是危害严重的妊娠期特有疾病，常伴有严重的母婴并发症，导致不良妊娠结局。低分子肝素有抗凝、抗炎、保护血管内皮细胞的作用，能从多方面对抗重度子痫前期的病理生理过程，可用于重度子痫前期早期的干预治疗，对降低母儿并发症及延缓疾病发展具有重要意义。

关键词: 重度子痫前期, 低分子肝素, 干预

CLC Number:

R714.24+4

DU Pei-li,CHEN Dun-jin.. Role of low-molecular-weight heparin in the early intervention of severe preeclampsia.[J]. Acta Metallurgica Sinica, DOI: 10.7504/fk2014090105.

杜培丽，陈敦金. 低分子肝素在重度子痫前期早期干预中的作用[J]. 中国实用妇科与产科杂志, DOI: 10.7504/fk2014090105.

References

[1］余艳红，沈立勇，钟梅，等．肝素治疗胎儿生长受限的临床观察［J］．中华妇产科杂志，2004，39：793-796.

[2］熊薇,周容. 子痫前期抗凝治疗安全性和有效性的循证评价［J］. 实用妇产科杂志,2010,26（9）:27-29.

[3］ Kanfer A, Bruch JF, Nguyen G, et al. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia［J］. J Technical Methods Pathol, 1996, 74(1): 253-258.

[4］邹敏, 郑穗瑾, 李秀艳. 低分子肝素治疗早发型重度子痫前期围生儿结局分析［J］. 中华妇幼临床医学杂志 (电子版), 2009, 5(2): 58-59.

[5］ Vaisbueh E, Romero R, Mazaki-Tovi S, et al. Retinol binding protein 4-a novel association with ealy-onset pre-eclampsia ［J］. J Perinat Med,2010,38:129-139.

[6］ Mello G, PaeRi E, Fatini C, et al. Low-molecular- weight heparin lowers the recurrence rate of preeclampsia and restors the physiological vaccular changes in angiotensin—converting enzyme DD women［J］. Hypertension,2010,45(1)：86-91.

[7］ Greer IA,Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy［J］.Blood,2005,106(2): 401-407.

[8］林建华,张建平,贺晶,等. 低分子肝素在产科中的应用［J］. 现代妇产科进展,2007,16(6): 401-403.

[9］ Bar J，Mashiah R，Cohen SB，et al. Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications［J］. Thromb Res，2001，101: 235-239.

[10］ Kupferminc M, Rimon E, Many A, et al. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia［J］. Blood Coagulation Fibrinolysis, 2011, 22(2):123-126.

[11］褚红女，黄荷凤. 肝素酶在产科领域的应用［J］.中华妇产科杂志，2003，38(7)：444-447.

[12］ Kim HJ, Jeong MH, Rhew JY, et al. Long-term clinical outcomes of platelet glycoprotein Ⅱb/Ⅱa inhibitor combined with acute coronary syndrome［J］. Circ J,2005,69(2):159-164.

[13］ Saisto T，Tiitinen A，Ulander VM，et al． Clinical cure of severe early onset pre－eclampsia with low molecular weight heparin therapy in primigravida with hyperreaction luteinalis and thrombophilia［J］. Human Reprod，2004,19(3):725-728．

[14］ Bates SM, Greer IA, Pabinger I, et al. Venous thromboembolism,thrombophilia,antithrombotic therapy, and pregnancy：American College of Chest Physicians Evidence-based Clinical Practice Guidelines［J］. Chest J,2008, 133(6): 844-886.

[15］张建平,郭仲杰. 早发型重度子痫前期凝血功能变化及抗凝治疗［J］.中国实用妇科与产科杂志，2009，25（4）：260-262.

[16］ Sameshima H, Kodama Y, Ikenoue T, et al. Antithrombin improves fetal condition in women with severe pre-eclampsia before 32 weeks of gestation: a randomized, double-blind, placebo-controlled trial［J］. J Obstet Gynaecol Res,2008,34(1):34-39.

[17］罗穗豫，王瑜. 低分子肝素治疗早发型重度子痫前期的临床资料回顾［J］.中国实用医药，2014，9（3）：1-3.

[18］ Kalk JJ, Huisjes AJ, Groot CJ, et al. Recurrence rate preeclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment［J］. Neth J Med, 2004,62(3):83-87.

[19］ Carlin AJ，Farquharson RG，Quenby SM，et al．Prospective observational study of bone mineral density during pregnancy：low molecular weight heparin versus control［J］．Hum Reprod，2004，19 (5)：1211-1214.

[1]	. [J]. Chinese Journal of Practical gynecology ang obstetric, 2022, 38(2): 134-137.
[2]	. [J]. Chinese Journal of Practical gynecology ang obstetric, 2021, 37(12): 1214-1219.
[3]	XIAO Yun-shan, LIN Xue-yan, ZHANG Xue-qin. Management of severe infection during puerperium. [J]. Chinese Journal of Practical gynecology ang obstetric, 2021, 37(10): 1016-1020.
[4]	. [J]. Acta Metallurgica Sinica, 2019, 35(4): 417-423.
[5]	. [J]. Acta Metallurgica Sinica, 2019, 35(12): 1333-1339.
[6]	WANG Tian-ping，ZHANG Guo-fu. Interventional therapy for fallopian tube obstructive infertility. [J]. Acta Metallurgica Sinica, 2019, 35(1): 83-86.
[7]	ANG Zi-lian，CHEN Han-qing. Healthy lifestyle management for gestational diabetes mellitus. [J]. Acta Metallurgica Sinica, 2018, 34(9): 976-979.
[8]	CAI Yan，WANG Xiao-ying. How to moniter and prevent severe preeclampsia. [J]. Acta Metallurgica Sinica, 2018, 34(5): 520-525.
[9]	BAO Chen-yi，LIU Xing-hui. Preconception care after obstetric and gynecologic vascular interventional surgery. [J]. Acta Metallurgica Sinica, 2018, 34(12): 1321-1324.
[10]	. [J]. Acta Metallurgica Sinica, 2017, 33(7): 705-708.
[11]	LIU Ming.. Labor management and intervention. [J]. Acta Metallurgica Sinica, 2016, 32(8): 730-734.
[12]	. [J]. Acta Metallurgica Sinica, 2015, 31(5): 421-425.
[13]	. [J]. Acta Metallurgica Sinica, 2015, 31(4): 276-280.
[14]	WANG Zi-lian,WU Yan-xin.. Intervention options and its necessity in the first-stage of labor. [J]. Acta Metallurgica Sinica, 2015, 31(2): 123-127.
[15]	LI Yuan-mei,DONG Rui-feng.. The changes of high density lipoprotein levels in early onset severe preeclampsia and the clinical significance. [J]. Acta Metallurgica Sinica, 2014, 30(9): 722-724.